Barclays’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.23M | Buy |
|
|||||
|
2024
Q3 | $900K | Buy |
|
|||||
|
2024
Q2 | $95K | Sell |
|
|||||
|
2024
Q1 | $14.9M | Buy |
|
|||||
|
2023
Q4 | $3.14M | Sell |
|
|||||
|
2023
Q3 | $6.13M | Buy |
|
|||||
|
2023
Q2 | $7.11M | Buy |
|
|||||
|
2023
Q1 | $8.95M | Sell |
|
|||||
|
2022
Q4 | $5.7M | Buy |
|
|||||
|
2022
Q3 | $2.54M | Buy |
|
|||||
|
2022
Q2 | $625K | Buy |
|
|||||
|
2022
Q1 | $398K | Sell |
|
|||||
|
2021
Q4 | $1.78M | Buy |
|
|||||
|
2021
Q3 | $1.17M | Buy |
|
|||||
|
2021
Q2 | $809K | Sell |
|
|||||
|
2021
Q1 | $1.69M | Buy |
|
|||||
|
2020
Q4 | $805K | Sell |
|
|||||
|
2020
Q3 | $859K | Sell |
|
|||||
|
2020
Q2 | $886K | Buy |
|
|||||
|
2020
Q1 | $329K | Sell |
|
|||||
|
2019
Q4 | $896K | Buy |
|
|||||
|
2019
Q3 | $471K | Sell |
|
|||||
|
2019
Q2 | $538K | Buy |
|
|||||
|
2019
Q1 | $529K | Buy |
|
|||||
|
2018
Q4 | $326K | Sell |
|
|||||
|
2018
Q3 | $682K | Buy |
|
|||||
|
2018
Q2 | $341K | Sell |
|
|||||
|
2018
Q1 | $800K | Buy |
|
|||||
|
2017
Q4 | $684K | Buy |
|
|||||
|
2017
Q3 | $322K | Buy |
|
|||||
|
2017
Q2 | $294K | Sell |
|
|||||
|
2017
Q1 | $416K | Buy |
|
|||||
|
2016
Q4 | $168K | Buy |
|
|||||
|
2016
Q3 | $6K | Sell |
|
|||||
|
2016
Q2 | $47K | Buy |
|
|||||
|
2016
Q1 | $3K | Sell |
|
|||||
|
2015
Q4 | $15K | Sell |
|
|||||
|
2015
Q3 | $1.02M | Buy |
|
|||||
|
2015
Q2 | $12K | Sell |
|
|||||
|
2015
Q1 | $88K | Buy |
|
|||||
|
2014
Q4 | $8K | Buy |
|
|||||
|
2014
Q3 | $2K | Sell |
|
|||||
|
2014
Q2 | $67K | Buy |
|
|||||
|
2014
Q1 | $6K | Buy |
|